For UK HealthTech & MedTech companies
You want to build a commercial presence with clinicians and clinics but don't have a structured approach
Reaching clinicians and building commercial relationships with clinics requires a different approach from standard B2B sales. Clinicians are time-poor, sceptical of commercial intent, and influenced more by peer evidence and clinical outcomes than by product features. Without a structured clinical engagement model, most approaches get ignored.
Cost of Inaction
Enter your target accounts, contracts live today, average contract value, and achievable conversion rate. The calculator shows the annual revenue gap from unconverted clinical relationships.
How it breaks down
- Current contracted revenue£270,000
- Revenue at target penetration£324,000
Two minutes, no typing, and I read every one myself.
From Paul
Tell me where that £54,000 is coming from, and I'll come back with the three things to fix first.
A few quick questions, about two minutes, and no typing. I read every one myself and reply with the three things costing you most and where I'd start. If it's useful, we talk. If not, you've still got a clear picture.
No obligation, no sales call unless you ask for one, and nothing automated lands in your inbox.
Paul, Solvable
- Clinicians express interest but don't progress to adoption
- No named clinical champions who actively advocate to peers
- Commercial conversation starts before clinical value is established
- Different clinician types (NHS vs private) require different approaches but get the same pitch
- clinical interest doesn't convert to contracted revenue
- sales cycles are long because clinical and commercial conversations aren't sequenced correctly
- approached as a vendor rather than a clinical partner
Frequently asked questions
Why does this problem persist?
Commercial teams in HealthTech and MedTech often approach clinicians the way they'd approach a procurement manager, with a product pitch. Clinicians respond to evidence, peer recommendation, and relevance to their specific patient population. The commercial motion needs to lead with clinical value before it asks for a commercial relationship.
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.